CLINICALLY FLAWLESS LTD

Executive Summary

CLINICALLY FLAWLESS LTD demonstrates a solid financial foundation with improving equity, positive working capital, and healthy cash reserves, indicative of good operational health for a young medical practice. The company is financially solvent with manageable liabilities and shows promising growth in retained earnings. Continued focus on cash flow management, cost control, and strategic growth will support sustained financial wellness.

CLINICALLY FLAWLESS LTD - Analysis Report

Company Number: 14183744

Analysis Date: 2025-07-29 17:52 UTC

Financial Health Assessment for CLINICALLY FLAWLESS LTD

---

1. Financial Health Score: B

Explanation:
CLINICALLY FLAWLESS LTD shows solid financial footing with positive net assets, improving working capital, and a stable cash position. The company’s balance sheet reflects good liquidity and equity growth over the past two years, indicating healthy operational cash flow and prudent management. However, the company is still relatively young (incorporated in 2022) and has modest asset levels, so while current indicators are good, scale and profitability should be monitored as the business matures.

---

2. Key Vital Signs

Metric	2024 Value	Interpretation
Cash at Bank	£2,942	Healthy cash reserve for a micro/small entity – good liquidity to cover short-term obligations.
Current Liabilities	£1,389	Short-term debts are manageable and well covered by current assets.
Net Current Assets (Working Capital)	£1,553	Positive working capital indicates the company can meet short-term liabilities comfortably.
Net Assets (Equity)	£1,981	Equity has grown significantly from £469 in 2023, showing retained earnings and financial stability.
Shareholders Funds	£1,981	Reflects owner’s stake and accumulated profits, a sign of financial strength in the early years.
Fixed Assets (Net Book Value)	£450	Modest fixed asset base appropriate for a service-oriented medical practice.
Trade Creditors	£600	Stable trade creditor balance, indicating consistent supplier relationships.
Taxation & Social Security Costs	£789	Increase from prior year but within reasonable limits; tax and payroll obligations are current.

---

3. Diagnosis: Financial "Health Check"

• Liquidity ("Pulse"): The company has a healthy "heartbeat" with cash and net current assets comfortably exceeding current liabilities. This suggests a strong ability to pay bills and manage day-to-day operations without liquidity stress.

• Solvency ("Structural Integrity"): The net asset position has quadrupled from 2023 to 2024, indicating the business is building equity and is solvent. This is akin to a strong skeletal frame supporting the company’s growth.

• Growth & Earnings ("Vital Signs Trend"): The increase in retained profits from £369 to £1,881 suggests profitable operations or effective capital management. The "symptom" here is a positive earnings trend, which is a good prognosis sign.

• Asset Management ("Organ Function"): Fixed assets are modest and depreciating at a steady rate, appropriate for a general medical practice. No signs of over-investment or asset impairment.

• Debt Management ("Stress Indicators"): Current liabilities are low relative to assets, and longer-term creditors have decreased significantly from £1,155 to £22, indicating debt repayment or restructuring – a positive "recovery" sign.

• Company Lifecycle Context: Being a relatively new company (2 years old), the financials show healthy development without overextension or distress signals common in startup phases.

---

4. Recommendations: Prescription for Financial Wellness

• Maintain Healthy Cash Flow: Continue monitoring cash reserves to ensure liquidity remains strong, especially as the company expands or invests in new equipment or services.

• Control Overhead Costs: Keep an eye on taxation and social security liabilities to avoid surprises. Timely payments help avoid penalties and maintain good supplier and HMRC relations.

• Plan for Growth: With strong equity growth, consider strategic investments or marketing to expand patient base and revenue streams. Careful budgeting will safeguard the company’s "immune system."

• Monitor Debtor Days: Although data on receivables is limited, ensure patient billing and collections are efficient to sustain working capital health.

• Audit Preparation: Although exempt from audit now, consider voluntary audits or financial reviews as the company grows, to provide assurance to stakeholders and aid in strategic planning.

• Risk Management: As the company operates in healthcare, maintain compliance with regulatory changes and insurance coverage to protect against operational risks.

---